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QUESTIONS
1. Describe cutaneous manifestations and the pathogenesis of autoimmune thyroid diseases.
2. Describe the normal function of the thyroid.
3. Explain the value of studying both messenger RNA and protein and the assay systems used.
4. What are the results of the study?
5. What are the limitations of the study?
6. What are the conclusions and clinical implications of the study?
Thyroid disease is common, and it often affects the skin. In fact, auto­
immune thyroid diseases (AITDs) such as Graves disease and chronic 
lymphocytic thyroiditis affect 5% of the population; accordingly, they are 
the most common organ­specific autoimmune diseases (Stassi and De 
Maria, 2002; Weetman, 2003; Jacobson and Tomer, 2007). Although cuta­
neous manifestations of AITD are well described and thyroid hormone is 
known to regulate the development and function of skin (Leonhardt and 
Heymann, 2002; Burman and McKinley­Grant, 2006), a better understand­
ing of these processes is needed. Therefore, Cianfarani et al. (2010, this 
issue) analyzed normal human skin, cultures of keratino cytes and dermal 
fibroblasts, and serum of patients with AITDs in hopes of elucidating the 
role of thyroid­specific molecules.
Cianfarani and colleagues studied thyroid­stimulating hormone receptor 
(TSH­R), thyroglobulin, sodium iodide symporter, and thyroperoxidase 
genes in various tissues and cultured cells. They found transcripts of each 
in normal skin; however, only TSH­R messenger RNA was observed routinely in keratinocytes and the fibroblast 
cell line. TSH was determined to be of functional importance because it induced the proliferation of keratino­
cytes and fibroblasts in culture, in part by increasing intracellular cAMP. Additionally, cAMP accumulation and 
its attendant cell proliferation were stimulated when the serum of patients affected by Graves disease (but not 
by chronic lymphocytic thyroiditis) was added to cultured keratinocytes.
Through the following questions, we examine this paper in greater detail. For discussion and brief answers, please 
refer to the supplementary information linked to the online version of the paper at http://www.nature.com/jid.
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